Recombinant Human Granulocyte Colony-stimulating Factor（rhG-CSF）
- Generic Name
- Recombinant Human Granulocyte Colony-stimulating Factor（rhG-CSF）
- Indication
用于：1.各种原因引起的中性粒细胞减少证，如恶性肿瘤和白血病化疗与放疗引起的中性粒细胞减少、造血干/祖细胞移植后髓系造血功能的受抑及延迟植活鱼移植排斥；
2.周围血造血干/祖细胞移植前的干/祖细胞动员等；
3.骨髓增生异常综合征（MDS）、再生障碍性贫血伴发的中性粒细胞减少，先天性、特发性、周期性中性粒细胞减少症，但远期疗效不肯定；
4.各种严重感染，包括艾滋病及并发的感染；
5.抗艾滋病药物引起的中性粒细胞减少症也可应用。
A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy
- Conditions
- OsteosarcomaBone Metastases
- Interventions
- Radiation: External beam radiotherapy.
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Albert Einstein College of Medicine
- Registration Number
- NCT03612466
- Locations
- 🇺🇸
Montefiore Medical Center-Children's Hospital, Bronx, New York, United States
GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial
- Conditions
- Ventilator Associated Pneumonia
- Interventions
- Drug: Guidelines-based antibiotics choice
- First Posted Date
- 2018-04-23
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Osaka General Medical Center
- Target Recruit Count
- 206
- Registration Number
- NCT03506113
- Locations
- 🇯🇵
Osaka General Medical Center, Osaka, Japan
🇯🇵Chukyo Hospital, Nagoya, Aichi, Japan
🇯🇵Sapporo City General Hospital, Sapporo, Hokkaido, Japan
To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2017-08-28
- Lead Sponsor
- Air Force Military Medical University, China
- Target Recruit Count
- 20
- Registration Number
- NCT03206684
- Locations
- 🇨🇳
Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China
Use of Gcsf in Patients With Recurrent Ivf/Icsi Failure
- First Posted Date
- 2017-01-18
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Ain Shams Maternity Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT03023774
PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia
- Conditions
- Lymphoma,Non-Hodgkin
- Interventions
- Drug: Pegylated rhG-CSF regimen
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2016-12-19
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT02996617
- Locations
- 🇨🇳
Department of Hematology, Provincial Hospital Affiliated to Shandong University, Jin'an, Shandong, China
PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2016-09-19
- Lead Sponsor
- Peking University
- Target Recruit Count
- 96
- Registration Number
- NCT02905942
- Locations
- 🇨🇳
Peking University Cancer Hospital, Beijing, China
A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 324
- Registration Number
- NCT02816164
- Locations
- 🇨🇦
The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 458
- Registration Number
- NCT02816112
- Locations
- 🇨🇦
The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2016-06-20
- Lead Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 215
- Registration Number
- NCT02805153
Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-11-10
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT02725086
- Locations
- 🇰🇷
Severance Hospital, Yonsei University College of Medicine, Seoul, Seodamun-gu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.